Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone.
Delaby C, Estellés T, Zhu N, Arranz J, Barroeta I, Carmona-Iragui M, Illán-Gala I, Santos-Santos MÁ, Altuna M, Sala I, Sánchez-Saudinós MB, Videla L, Valldeneu S, Subirana A, Tondo M, Blanco-Vaca F, Lehmann S, Belbin O, Blesa R, Fortea J, Lleó A, Alcolea D. Delaby C, et al. Among authors: lehmann s. Alzheimers Res Ther. 2022 Feb 1;14(1):20. doi: 10.1186/s13195-022-00967-z. Alzheimers Res Ther. 2022. PMID: 35105351 Free PMC article.
Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.
Gabelle A, Roche S, Gény C, Bennys K, Labauge P, Tholance Y, Quadrio I, Tiers L, Gor B, Boulanghien J, Chaulet C, Vighetto A, Croisile B, Krolak-Salmon P, Perret-Liaudet A, Touchon J, Lehmann S. Gabelle A, et al. Among authors: lehmann s. J Alzheimers Dis. 2011;26(3):553-63. doi: 10.3233/JAD-2011-110515. J Alzheimers Dis. 2011. PMID: 21709372 Free article.
Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting.
Dumurgier J, Vercruysse O, Paquet C, Bombois S, Chaulet C, Laplanche JL, Peoc'h K, Schraen S, Pasquier F, Touchon J, Hugon J, Lehmann S, Gabelle A. Dumurgier J, et al. Among authors: lehmann s. Alzheimers Dement. 2013 Jul;9(4):406-13. doi: 10.1016/j.jalz.2012.06.006. Epub 2012 Nov 8. Alzheimers Dement. 2013. PMID: 23141384 Clinical Trial.
Biomarkers of Alzheimer's disease: the present and the future.
Lehmann S, Delaby C, Touchon J, Hirtz C, Gabelle A. Lehmann S, et al. Rev Neurol (Paris). 2013 Oct;169(10):719-23. doi: 10.1016/j.neurol.2013.07.012. Epub 2013 Sep 7. Rev Neurol (Paris). 2013. PMID: 24021316 Review.
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.
Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc'h K, Rouaud O, Sablonnière B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A. Lehmann S, et al. Alzheimers Dement. 2014 Oct;10(5 Suppl):S390-S394.e2. doi: 10.1016/j.jalz.2013.06.008. Epub 2013 Oct 23. Alzheimers Dement. 2014. PMID: 24269268
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.
Lehmann S, Dumurgier J, Schraen S, Wallon D, Blanc F, Magnin E, Bombois S, Bousiges O, Campion D, Cretin B, Delaby C, Hannequin D, Jung B, Hugon J, Laplanche JL, Miguet-Alfonsi C, Peoc'h K, Philippi N, Quillard-Muraine M, Sablonnière B, Touchon J, Vercruysse O, Paquet C, Pasquier F, Gabelle A. Lehmann S, et al. Alzheimers Res Ther. 2014 Jun 26;6(3):38. doi: 10.1186/alzrt267. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25478015 Free PMC article.
1,176 results